Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Lice Treatment Market

Lice Treatment Market Size

  • Report ID: GMI9176
  • Published Date: Apr 2024
  • Report Format: PDF

Lice Treatment Market Size

Lice Treatment Market size was valued at USD 1 billion in 2023 and is expected to exhibit growth of 6.5% from 2024 to 2032. The rising prevalence of lice infestations is a significant factor propelling the market growth.

 

Lice infestations are highly contagious, particularly in settings where people are in close contact, such as schools, childcare facilities, camps, and households. The ease of transmission through direct head-to-head contact or sharing of personal items, such as hats, combs, and clothing, increases the risk of infestation among individuals in these environments. Thus, widespread usage of drugs among the aforementioned scenario will spur the market growth.

 

Lice treatment refers to the process of eliminating infestations of lice, which are parasitic insects that commonly affect humans and other mammals. The goal of lice treatment is to eradicate both the adult lice and their eggs from the affected individual's body or environment, thereby stopping the infestation and preventing its spread to others. Further, the lice treatment methods typically involve the use of medicated shampoos, lotions, or sprays containing insecticides or other active ingredients that kill lice.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Lice treatment industry size recorded USD 1 billion in 2023 and is expected to register 6.5% CAGR from 2024 to 2032, due to the rising prevalence of lice infestations.

The OTC products segment in the market accounted for 62.6% share in 2023 and is projected to witness substantial growth from 2024 to 2032, on account of the rising environmental concerns along with consumer demand for non-toxic, eco-friendly products.

North America lice treatment industry accumulated USD 461.5 million in revenue in 2023 and is expected to expand at 6.4% CAGR from 2024 to 2032, due to the presence of a larger infestation pool and the increasing children population in the region.

Alliance Pharma PLC, Azurity Pharmaceuticals, Inc., Fleming Medical Ltd., Oystershell Consumer Health, Parapro Pharmaceuticals, Perrigo Company plc, Prestige Consumer Healthcare Inc., Reckitt Benckiser Group plc, Sanofi S.A., and Thornton & Ross Ltd.

Lice Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 221
  • Countries covered: 19
  • Pages: 140
 Download Free Sample